No abstract

This national survey is the largest series of nasal vestibule cancer ever published. Wang classification is more prognostic and easier to use than the Union Internationale Contre le Cancer 2002. Surgery or hypofractionated RT can be used for T1 lesions, whereas larger lesions should be treated with combined approach.

Emphasis on hearing preservation has led to recognition of the round window membrane (RWM) as a portal for the cochlear implant electrode array. The St Thomas' Hospital (STH) classification was devised to evaluate the accessibility of RWM electrode insertion. The objectives of this study were: (1) to prospectively evaluate the STH classification in selecting the appropriate cochlear insertion route in "RWM-intentioned" cases, and (2) to ascertain if RWM accessibility differs from adults to children. This was a prospective cohort study of consecutive patients (adult and paediatric) undergoing cochlear implantation at a specialist auditory implant centre. Visibility of the RWM was graded according to the STH classification after an "optimal" posterior tympanotomy had been performed and any overhang of the bony round window niche removed without breaching the RWM. Most adult (89 %) and paediatric (78 %) cases had more than 50 % of the RWM exposed (Types I and IIa). Cases having less than 50 % of RWM exposed (Types IIb) or none exposed (Type III) were twice as common in children (p = 0.004). 96 % of Type I and 63 % of Type IIa cases underwent RWM insertion through a membranous cochleostomy. 71 % of Type IIb necessitated an extended membranous cochleostomy. All Type III cases required a conventional bony cochleostomy. When more than 50 % of RWM was visible (Types I and IIa), 88 % underwent a membranous cochleostomy. For "RWM-intentioned" cases, the STH classification can be a sensible method of relating RWM visibility/accessibility to the optimal route for insertion. This study also demonstrates that RWM insertion is more challenging in children.

■ AbstractThe diterpene glycoside stevioside (SVS) and soy bean protein isolate have both been shown to have beneficial effects in diabetes treatment. As they each show different benefits we investigated whether the combination of both substances shows an improvement in the treatment of diabetes in Goto-Kakizaki (GK) rats. Over the course of 4 wk, the rats were fed with the following four test diets (n = 12 per group): 1. Standard carbohydrate-rich laboratory diet (chow), 2. chow + SVS (0.03 g/kg BW/day), 3. 80% SPI + 20% chow and 4. 80% SPI + 20% chow + SVS (0.03 g/kg BW/day). At the end of the course conscious rats underwent an intra-arterial glucose tolerance test (IAGTT) (2.0 g glucose/kg BW). Compared to normal chow diet, stevioside in combination with SPI shows the following beneficial effects in GK rats with mild type 2 diabetes: 1. a 56% reduction in plasma glucose (p < 0.001), 2. a 118% increase in first-phase insulin (p < 0.005), 3. a 20% reduction in glucagons (p < 0.05), 4. a 28% reduction in total cholesterol (p < 0.001), 5. a 13% reduction in FFA (p < 0.01), 6. a 49% reduction in TG (p < 0.001) and 7. a 11% reduction in the systolic blood pressure (p < 0.001). In conclusion, the combination of stevioside and SPI has synergistic positive effects on the characteristic features of the metabolic syndrome, i.e. hyperglycemia, hypertension and dyslipidemia.